SCHEDULE: Baird Entities Report Stake in Sanara MedTech

Baird Trust Company, Baird Financial Corporation, and Baird Financial Group, Inc. have collectively reported beneficial ownership of 21,075 shares of Sanara MedTech Inc. common stock.

Summary

• Baird Trust Company (BTC), Baird Financial Corporation (BFC), and Baird Financial Group, Inc. (BFG) have filed a Schedule 13G, indicating their beneficial ownership of Sanara MedTech Inc. common stock.
• The total number of shares beneficially owned by these entities is 21,075.
• This ownership represents 0.0% of the class of common stock outstanding as of March 20, 2026.
• The filing clarifies that the ownership is due to investment discretion or voting authority granted to BTC by its clients.
• The reporting entities explicitly state that this filing should not be construed as an admission of beneficial ownership for the purposes of Section 13(d) or 13(g) of the Act.
• BTC is a Kentucky corporation, while BFC and BFG are Wisconsin corporations.
• BTC is directly owned by BFC, which is ultimately owned by BFG.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a low score due to the purely informational nature of the filing and the insignificant ownership percentage, which offers no new strategic insights or financial performance indicators.

Positives

• Disclosure of beneficial ownership by significant financial entities can provide transparency to the market.
• The reporting entities are acting in accordance with SEC regulations for disclosure.

Negatives

• The reported ownership stake is negligible (0.0%) and unlikely to have any significant influence on the company's control or direction.

Risks

• The filing does not mention any specific risks related to the ownership stake or Sanara MedTech Inc.'s operations.

Future Outlook

No forward-looking statements or guidance are provided in this filing, as it is a disclosure of beneficial ownership.

Management Comments

• The reporting persons expressly declare that the filing of this Schedule shall not be construed as an admission that a Reporting Person is, for purposes of Section 13(d) or 13(g) of the Act, the beneficial owner of any securities covered by this Schedule.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures for institutional investors and other entities that acquire beneficial ownership of more than 5% of a class of a company's registered equity securities. This filing indicates a passive stake, as the ownership percentage is below the typical threshold for active influence.

Stakeholder Impact

• Shareholders: The filing provides transparency regarding ownership, but the minimal stake is unlikely to impact share price or corporate strategy.
• Management: No direct impact on management operations or decisions is indicated by this filing.
• Creditors: No impact on creditors is expected as the ownership stake is not significant enough to influence financial stability.

Next Steps

• No specific next steps are outlined in this filing, as it is a disclosure of existing beneficial ownership.

Key Dates

Keywords

Schedule 13G, Sanara MedTech Inc., Baird Trust Company, Baird Financial Corporation, Baird Financial Group, Beneficial Ownership, Common Stock, SEC Filing